The present invention relates to a transdermal fluid wherein the main ingredient is tocotrienol; and curcumin is added to enhance the anti-cancer effects of tocotrienols. The composition is useful for the treatment or prevention of a cancer or a tumour or an inflammatory disorder, particularly breast cancer.